Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT AMLODIPINE 5MG TABLET Resolved 2022-12-15 2023-02-16 178518
ACT AMLODIPINE 10MG TABLET Resolved 2021-09-30 2021-10-07 146443
ACT AMLODIPINE 2.5MG TABLET Resolved 2017-03-17 2017-09-19 3348
ACT AMLODIPINE 5MG TABLET Resolved 2023-02-09 2023-04-28 184204
ACT AMLODIPINE 5MG TABLET Resolved 2020-11-06 2021-01-07 127998
ACT AMLODIPINE 10MG TABLET Resolved 2020-11-06 2021-01-21 128034
ACT AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
ACT AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
ACT AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
ACT AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-05-06 131679
ACT AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-15 2021-09-09 142610
ACT AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2021-09-23 2021-10-14 146092
ACT AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Avoided shortage 2021-05-20 2021-07-08 139722
ACT AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
ACT AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2021-03-25 2021-05-20 136286
ACT AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
ACT AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-03-11 131676
ACT AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
ACT ANASTROZOLE 1MG TABLET Resolved 2020-01-24 2021-01-28 104374
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-09-25 2020-10-22 125031

Showing 1 to 20 of 3247

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LAMOTRIGINE 150MG TABLET Discontinued 2025-05-28 2025-05-28 258652
TEVA-LAMOTRIGINE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258646
TEVA-LAMOTRIGINE 25MG TABLET Discontinued 2019-04-11 2019-04-11 81388
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258507
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258510
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-29 2025-04-29 256085
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-25 2025-04-25 255824
TEVA-LATANOPROST 50MCG SOLUTION Discontinued 2020-07-10 2020-07-10 120009
TEVA-LEVOCARBIDOPA 25MG 250MG TABLET Discontinued 2025-05-28 2025-05-28 258625
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2018-10-19 2018-10-19 64909
TEVA-LISINOPRIL (TYPE P) 10MG TABLET Discontinued 2019-04-11 2019-04-11 81400
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2018-10-12 2018-10-12 63978
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2020-01-24 2020-01-24 104257
TEVA-LISINOPRIL (TYPE Z) 20MG TABLET Discontinued 2025-05-28 2025-05-28 258694
TEVA-LISINOPRIL (TYPE Z) 5MG TABLET Discontinued 2025-05-28 2025-05-28 258699
TEVA-LISINOPRIL (TYPE Z) 10MG TABLET Discontinued 2019-08-15 2019-08-15 91648
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301